Onesource Specialty Pharma Ltd.
ONESOURCE
Rank in Stocks
#5948
OneSource Specialty Pharma Limited is a biopharmaceutical company focused on... OneSource Specialty Pharma Limited is a biopharmaceutical company focused on the discovery, advancement, production, and market introduction of biological drug products, primarily offered in diverse injectable formulations. The company conducts its operations internationally, with a footprint in India, Ireland, and the United States. It delivers comprehensive contract development and manufacturing (CDMO) services for biologics, encompassing all phases from preclinical and clinical development to commercial-scale supply. Its offerings extend to integrated drug-device systems such as pre-filled syringes, various pen injectors (including dial, push, and pull-push types for both variable and fixed doses), and autoinjectors. Furthermore, OneSource Specialty Pharma manufactures sterile injectable drugs and soft gelatin capsules, and provides specialized biologics solutions tailored for microbial and mammalian cell-line biopharmaceuticals, as well as for cell, gene, and RNA therapies. Established in 2007, the company, headquartered in Bengaluru, India, was formerly known as Stelis Biopharma Limited until its rebranding in February 2024.
Share Price
$17.22
Last synced: 2026-11-09
Market Cap
$1.97B
Change (1 day)
1.69%
Change (1 year)
-13.09%
Country
Stock data: Financial Modeling PrepยทUpdated ยทNot investment adviceยทHow we calculate this
Trade Onesource Specialty Pharma Ltd. (ONESOURCE)
Category
Healthcare
Operating Margin for Onesource Specialty Pharma Ltd. (ONESOURCE)
Operating Margin as of November 2026 TTM: 6.39%
According to Onesource Specialty Pharma Ltd.'s latest financial reports, its current operating margin (TTM) is 6.39%. At the end of 2025 the company had an operating margin of 13.18%.
Operating Margin history for Onesource Specialty Pharma Ltd. from 2025 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | 6.39% | -51.52% |
| 2025 | 13.18% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| 38.59% | -93.96% |
US
|
|
| -149.01% | -123.32% |
US
|
|
| 25.57% | -96.00% |
AU
|
|
| 31.23% | -95.11% |
BE
|
|
| 29.35% | -95.41% |
NL
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.
Questions about Onesource Specialty Pharma Ltd.'s operating margin
What is Onesource Specialty Pharma Ltd.'s operating margin?
Onesource Specialty Pharma Ltd.'s operating margin is 6.39%, as of Nov 2026.
How does Onesource Specialty Pharma Ltd.'s operating margin compare with similar companies?
Onesource Specialty Pharma Ltd.'s operating margin (6.39%) is higher than that of 1 of the 5 similar companies listed above. The highest among them is Vertex Pharmaceuticals Incorporated, with 38.59%.